Carl von Ossietzky University Oldenburg

Since 2022, the Institute for Medical Microbiology and Virology at the University of Oldenburg has been involved in a project to characterise carbapenem resistance in carbapenemase-producing Enterobacterales (CPE). Together with the group of Dr Andreas Wendel at the Kliniken der Stadt Köln, the Oldenburg group led by Prof. Axel Hamprecht is providing CPE isolates as well as epidemiological data for the pilot study “Dissemination of carbapenemase genes by mobile genetic elements (DIOGENES)”, which is being conducted under the leadership of the University Hospital Tübingen.

Carl von Ossietzky University Oldenburg